A recent report suggested transfection of c-Kit in parental multiple myeloma (MM) cells in the presence of stem cell factor (SCF) up-regulated SLUG and increased resistance to the chemotherapeutic agents. The gene discussed is KITLG; the disease is Miyoshi myopathy.